High expression of PHGDH predicts poor prognosis in non-small cell lung cancer

Translational Oncology

Volumn 9, Issue 6, 2016, Pages 592-599

  Zhu, Jinhong ^a   Ma, Jianqun ^a   Wang, Xudong ^b   Ma, Tianjiao ^a   Zhang, Shu ^b   Wang, Wei ^b   Zhou, Xiaoyu ^b   Shi, Jiahai ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PHOSPHOGLYCERATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL LUNG CARCINOMA; TISSUE MICROARRAY;

EID: 85001048567     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1016/j.tranon.2016.08.003     Document Type: Article

References (35)

1. Cairns RA, Harris IS, and Mak TW (2011). Regulation of cancer cell metabolism. Nat Rev Cancer 11(2), 85-95
2. Wallace DC (2012). Mitochondria and cancer. Nat Rev Cancer 12(10), 685-698
3. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, and Thompson CB (2008). The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7(1), 11-20
4. Vander Heiden MG, Cantley LC, and Thompson CB (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930), 1029-1033
5. Koppenol WH, Bounds PL, and Dang CV (2011). Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11(5), 325-337
6. Sotgia F, Martinez-Outschoorn UE, and Lisanti MP (2012). Genetic induction of the Warburg effect inhibits tumor growth. Oncotarget 3(11), 1266-1267
7. Galluzzi L, Kepp O, and Kroemer G (2012). Reverse Warburg: straight to cancer. Cell Cycle 11(6), 1059
8. Locasale JW, Grassian AR, and Melman T, et al (2011). Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 43(9), 869-874
9. Kit S (1955). The biosynthesis of free glycine and serine by tumors. Cancer Res 15(11), 715-718
10. Possemato R, Marks KM, and Shaul YD, et al (2011). Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476(7360), 346-350
11. Pollari S, Kakonen SM, and Edgren H, et al (2011). Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis. Breast Cancer Res Treat 125(2), 421-430
12. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, and Jemal A (2015). Global cancer statistics, 2012. CA Cancer J Clin 65(2), 87-108
13. Goldstraw P (2009). The 7th edition of TNM in lung cancer: what now? J Thorac Oncol 4(6), 671-673
14. Lu C, Wang X, Zhu H, Feng J, Ni S, and Huang J (2015). Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer. Oncotarget 6(28), 24912-24921
15. Sun R, Wang X, and Zhu H, et al (2014). Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues. Oncotarget 5(23), 12398-12409
16. Chen R, Lu M, and Wang J, et al (2013). Increased expression of Trop2 correlates with poor survival in extranodal NK/T cell lymphoma, nasal type. Virchows Arch 463(5), 713-719
17. Gyorffy B, Surowiak P, Budczies J, and Lanczky A (2013). Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One 8(12), e82241
18. Hanahan D and Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell 144(5), 646-674
19. Jing Z, Heng W, and Xia L, et al (2015). Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3. Cancer Biol Ther 16(4), 541-548
20. Yoon S, Kim JG, and Seo AN, et al (2015). Clinical Implication of serine metabolism-associated enzymes in colon cancer. Oncology 89(6), 351-359
21. Nikiforov MA, Chandriani S, and O'Connell B, et al (2002). A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol Cell Biol 22(16), 5793-5800
22. Chen J, Chung F, and Yang G, et al (2013). Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth. Oncotarget 4(12), 2502-2511
23. Gromova I, Gromov P, and Honma N, et al (2015). High level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancy. Mol Oncol 9(8), 1636-1654
24. DeNicola GM, Chen PH, and Mullarky E, et al (2015). NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat Genet 47(12), 1475-1481
25. DeBerardinis RJ (2011). Serine metabolism: some tumors take the road less traveled. Cell Metab 14(3), 285-286
26. Mullarky E, Lucki NC, and Beheshti Zavareh R, et al (2016). Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. Proc Natl Acad Sci U S A 113(7), 1778-1783
27. Pacold ME, Brimacombe KR, and Chan SH, et al (2016). A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat Chem Biol 12(6), 452-458
28. Locasale JW (2013). Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer 13(8), 572-583
29. Vander Heiden MG, Locasale JW, and Swanson KD, et al (2010). Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329(5998), 1492-1499
30. Locasale JW and Cantley LC (2010). Altered metabolism in cancer. BMC Biol 8, 88
31. Eng CH, Yu K, Lucas J, White E, and Abraham RT (2010). Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci Signal 3(119), ra31
32. Fumarola C, Bonelli MA, Petronini PG, and Alfieri RR (2014). Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer. Biochem Pharmacol 90(3), 197-207
33. Chen J, Zhang XD, and Proud C (2015). Dissecting the signaling pathways that mediate cancer in PTEN and LKB1 double-knockout mice. Sci Signal 8(392), pe1
34. Heavey S, O'Byrne KJ, and Gately K (2014). Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC. Cancer Treat Rev 40(3), 445-456
35. Soria JC, Marabelle A, Brahmer JR, and Gettinger S (2015). Immune checkpoint modulation for non-small cell lung cancer. Clin Cancer Res 21(10), 2256-2262.